GS030-MD

Asset

Stimulating glasses deliver light patterns to activate retinal cells sensitized by GS030-DP gene therapy.

Stage
Phase 1
Modality
Device
Target
Not known
1
Indication
1
Trial
1
Developer

Indications

1

In the full profile

  • Owner and partners1
  • Trials1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets